Takeda Pharmaceutical Company Limited company logo
Takeda Pharmaceutical Company Limited logo

TAK Cash From Financing

Annual CFF

-$4.19B$2.43B-138.38%

Summary

Current Value
As of today, TAK annual cash from financing is -$4.19B, down -138.38% on
Historical Performance
TAK annual cash from financing is up +51.08% over the past 3 years, and up +48.14% over the past 5 years
All-Time High Comparison
TAK annual cash from financing is currently -115.58% below its historical high of $26.88B set on
3-Year Low Comparison
TAK annual cash from financing is +51.08% above its 3-year low of -$8.56B reached on an earlier date
Sector Comparison
TAK annual cash from financing is higher than 1.27% of companies in Healthcare sector

Cash From Financing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

TAK Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Financing-$4.19B-138.4%+51.1%+48.1%-162.7%
Quarterly Cash From Financing$168.59M+131.8%+249.8%+108.6%+226.7%
TTM Cash From Financing-$6.98B-880.5%-49.3%-53.4%-319.4%
Price$15.90+19.1%+2.0%-11.2%-33.1%
Annual Cash From Operations$6.31B+42.6%-30.5%+23.6%+53.8%
Annual Cash From Investing-$2.53B+25.1%-38.9%-198.4%-99.7%
Annual Dividends Paid$1.98B-0.1%-21.4%-23.6%+28.4%
Annual Total Debt$34.03B-5.7%-14.1%-32.8%+10000.0%
Shares Outstanding3.16B-0.4%+1.6%+1.0%

Cash From Financing Highs

TAK Annual Cash From Financing Highs Comparison
PeriodHighDateCurrent
3Y-$1.76B-138.4%
5Y-$1.76B-138.4%
All$26.88B-115.6%

Cash From Financing Lows

TAK Annual Cash From Financing Lows Comparison
PeriodLowDateCurrent
3Y-$8.56BN/A+51.1%
5Y-$9.25B+54.7%
All-$9.25B+54.7%

Cash From Financing History

YearValueChange
-$4.19B-138.4%
-$1.76B+60.4%
-$4.43B+48.2%
-$8.56B+7.4%
-$9.25B-14.5%
-$8.08B-130.0%
YearValueChange
$26.88B+1,037.4%
-$2.87B-204.6%
$2.74B+374.5%
-$998.88M+61.5%
-$2.59B-

FAQ

  • What is the current annual cash from financing of TAK?

    As of today, TAK annual cash from financing is -$4.19B

  • What is 1-year change in TAK annual cash from financing?

    TAK annual cash from financing is down -138.38% year-over-year

  • What is 3-year change in TAK annual cash from financing?

    TAK annual cash from financing is up +51.08% over the past 3 years

  • How far is TAK annual cash from financing from its all-time high?

    TAK annual cash from financing is currently -115.58% below its historical high of $26.88B set on March 31, 2019

  • How does TAK annual cash from financing rank versus sector peers?

    TAK annual cash from financing is higher than 1.27% of companies in Healthcare sector

  • When is TAK next annual earnings release?

    As of today, the next annual earnings release for TAK has not been scheduled

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

  1. TAK Official Website www.takeda.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1395064/000139506425000095/0001395064-25-000095-index.htm
  3. TAK Profile on Yahoo Finance finance.yahoo.com/quote/TAK
  4. TAK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tak